MedPath

康方药业有限公司

Ownership
-
Established
2017-08-10
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Cadonilimab Injection

Product Name
开坦尼
Approval Number
国药准字S20220018
Approval Date
Jun 28, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.